bioAffinity Technologies, Inc. (BIAF)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.00M
Last updated: Nov 17, 2026 at 4:24 PM ET
bioAffinity Technologies, Inc. (BIAF) Stock Chart
bioAffinity Technologies (BIAF) has a latest price of $1.93 on Nov 17, 2026. Its price fell 93.0% over the past 12 months. The month-end price fell 99.5% over the 3 years through Oct 2026, a compound annual decline of 82.8%.
Price Chart
From Sep 2022 to Oct 2026, its highest month-end close was $1,310.16 in Sep 2022 and its lowest $2.91 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BIAF with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BIAF.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 68.5%, and over 6 months it fell 92.4%.
| Period | Change |
|---|---|
| 1 month | -45.0% |
| 3 months | -68.5% |
| 6 months | -92.4% |
| 12 months | -93.0% |
| 12 months, with dividends | -93.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.5% | -82.8% |
Price by Year
Its best calendar year was 2023, when the price fell 8.1%, and its weakest was 2025, when it fell 95.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $2.91 | -83.6% |
| 2025 | $17.69 | -95.7% |
| 2024 | $409.71 | -38.1% |
| 2023 | $662.06 | -8.1% |
Trading Range
The price is 61.1% below its 50-day average of $4.96 and 89.4% below its 200-day average of $18.23.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.93 | |
| 50-day average | $4.96 | -61.1% |
| 200-day average | $18.23 | -89.4% |
Price Risk
Over 3 years, its largest fall from a peak was 99.9%.
| Measure | Value |
|---|---|
| 1-year beta | 2.01 |
| Largest fall, 1 year | -97.3% |
| Largest fall, 3 years | -99.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BIAF
What is BIAF's 1-year price change?
bioAffinity Technologies's price fell 93.0% over the past 12 months. With dividends included, the 12-month total return was -93.0%.
How has BIAF stock done over the long term?
bioAffinity Technologies's month-end price fell 99.5% over the 3 years through Oct 2026, a compound annual decline of 82.8%. These figures leave out dividends.
What is BIAF's beta?
bioAffinity Technologies's 1-year beta against the S&P 500 is 2.01, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 97.3%.
Is the BIAF chart free?
Yes. Advanced Charting for BIAF is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BIAF pages: Overview, Charting, Earnings, Financials, Statistics, Competitors